Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Terminated Phase 1 Trials for Sorafenib (DB00398)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01159301Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaTreatment